Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
BIRGIT EHLKEN
Observed names:
B Ehlken,
B. Ehlken,
Birgit Ehlken,
Ehlken, Birgit
Institution:
IQVIA (United States)
Observed institutions:
Innsbruck Medical University,
University of Cologne,
IQVIA (United States),
LKH Hochsteiermark,
University Hospital Cologne,
University Hospital Innsbruck,
Stiftung Charité,
Charité – Universitätsmedizin Berlin,
Ruhr University Bochum
show all 9
ORCID:
0000-0003-4751-4220
Observed ORCID:
0000-0003-4751-4220
OpenAlex ID:
A5086921771
Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation
2016
·
Jan Beyer-Westendorf
, Birgit Ehlken
, et al.
·
EP Europace
·
169
Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1‐yr retrospective study
2003
·
B. Schramm
, B. Ehlken
, et al.
·
European Respiratory Journal
·
168
PDF
The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers
2004
·
A. Ihbe-Heffinger
, B. Ehlken
, et al.
·
Annals of Oncology
·
146
PDF
Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany
2005
·
Birgit Ehlken
, Gabriele Ihorst
, et al.
·
European Journal of Pediatrics
·
128
Cost‐of‐illness in patients with moderate and severe chronic psoriasis vulgaris in Germany
2005
·
Karin Berger
, Birgit Ehlken
, et al.
·
JDDG Journal der Deutschen Dermatologischen Gesellschaft
·
111
International variation in disease burden of rotavirus gastroenteritis in children with community- and nosocomially acquired infection
2001
·
MARTIN FRÜHWIRTH
, ULRICH HEININGER
, et al.
·
The Pediatric Infectious Disease Journal
·
105
Prospective population-based study on rotavirus disease in Germany
2002
·
B Ehlken
, B Laubereau
, et al.
·
Acta Paediatrica
·
68
Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX®) therapy in Germany
2009
·
Björn Wefer
, Birgit Ehlken
, et al.
·
World Journal of Urology
·
61
Twice‐weekly treatment with tacrolimus 0.03% ointment in children with atopic dermatitis: clinical efficacy and economic impact over 12 months
2010
·
D Thaci
, C Chambers
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
58
Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review
2016
·
Diana M. Eccles
, Judith Balmaña
, et al.
·
Advances in Therapy
·
57
Burden of pulmonary arterial hypertension in Germany
2010
·
H. Wilkens
, F. Grimminger
, et al.
·
Respiratory Medicine
·
57
Cost for physician-diagnosed influenza and influenza-like illnesses on primary care level in Germany – results of a database analysis from May 2010 to April 2012
2015
·
Birgit Ehlken
, Anastassia Anastassopoulou
, et al.
·
BMC Public Health
·
54
PDF
Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany
2006
·
Florian Lordick
, Birgit Ehlken
, et al.
·
European Journal of Cancer
·
52
Treatment patterns and cost‐of‐illness of severe haemophilia in patients with inhibitors in Germany
2004
·
G. Auerswald
, M. von Depka Prondzinski
, et al.
·
Haemophilia
·
47
PDF
Krankheitskostenstudie bei Patienten mit atopischem Ekzem in Deutschland
2005
·
B. Ehlken
, M. Möhrenschlager
, et al.
·
Der Hautarzt
·
46
Economic impact of community- and nosocomially acquired rotavirus gastroenteritis in Austria
2001
·
MARTIN FR??HWIRTH
, KARIN BERGER
, et al.
·
The Pediatric Infectious Disease Journal
·
45
REal-LIfe Evidence of stroke prevention in patients with atrial Fibrillation — The RELIEF study
2015
·
Craig I. Coleman
, Matthias Antz
, et al.
·
International Journal of Cardiology
·
43
Economic evaluation of maintenance treatment with tacrolimus 0·1% ointment in adults with moderate to severe atopic dermatitis
2008
·
A. Wollenberg
, M.K. Sidhu
, et al.
·
British Journal of Dermatology
·
41
Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017
2018
·
Birgit Ehlken
, Lennart Nathell
, et al.
·
Drug Safety
·
37
PDF
Cost of atherothrombotic diseases—myocardial infarction, ischaemic stroke and peripheral arterial occlusive disease—in Germany
2005
·
B. Brüggenjürgen
, H.-J. Rupprecht
, et al.
·
Journal of Public Health
·
36
Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program
2015
·
for the C.A.R.E. Study Group
, Zaza Katsarava
, et al.
·
BMC Neurology
·
27
PDF
Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitals
2012
·
C. T. Rieger
, O. A. Cornely
, et al.
·
Mycoses
·
26
Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany
2011
·
L. Breitscheidel
, B. Ehlken
, et al.
·
Journal of Medical Economics
·
25
PDF
[Rotavirus gastroenteritis in infants and children. Results of a prospective study in the area of Geneva and Basel 1997/1998 (RoMoS). RoMoS Study Group].
1999
·
B Laubereau
, S Gateau
, et al.
·
Swiss Medical Weekly
·
18
Long-term cost-effectiveness of clopidogrel in patients with acute coronary syndrome without ST-segment elevation in Germany
2006
·
B. Brüggenjürgen
, P. Lindgren
, et al.
·
The European Journal of Health Economics
·
17
Show more works
View as search
Works count:
91
Citation count:
1,750
H-index:
23
I10-index:
28
Year
Topic
Type